A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)
Clinical trial NCT01206517 · COMPLETED
Trial details
- NCT number
- NCT01206517
- Sponsor
- Organon and Co
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-18
- Primary completion
- 2011-08-04
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.